EA202192584A1 - PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES - Google Patents

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES

Info

Publication number
EA202192584A1
EA202192584A1 EA202192584A EA202192584A EA202192584A1 EA 202192584 A1 EA202192584 A1 EA 202192584A1 EA 202192584 A EA202192584 A EA 202192584A EA 202192584 A EA202192584 A EA 202192584A EA 202192584 A1 EA202192584 A1 EA 202192584A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
complement
pharmaceutical compounds
mediated diseases
disorders
Prior art date
Application number
EA202192584A
Other languages
Russian (ru)
Inventor
Джейсон Аллен Уайлз
Венкат Рао Гадхачанда
Кайл Дж. Истмэн
Original Assignee
Акиллион Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акиллион Фармасьютикалз, Инк. filed Critical Акиллион Фармасьютикалз, Инк.
Priority claimed from PCT/US2020/024017 external-priority patent/WO2020198062A1/en
Publication of EA202192584A1 publication Critical patent/EA202192584A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В данном описании предложены фармацевтические соединения для лечения медицинских расстройств, таких как расстройства, опосредованные комплементом, включая расстройства, опосредованные комплементом C1.Provided herein are pharmaceutical compounds for the treatment of medical disorders such as complement mediated disorders, including C1 complement mediated disorders.

EA202192584A 2019-12-20 2020-03-20 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES EA202192584A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962951669P 2019-12-20 2019-12-20
PCT/US2020/024017 WO2020198062A1 (en) 2019-03-22 2020-03-20 Pharmaceutical compounds for the treatment of complement mediated disorders

Publications (1)

Publication Number Publication Date
EA202192584A1 true EA202192584A1 (en) 2022-02-01

Family

ID=80631329

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192584A EA202192584A1 (en) 2019-12-20 2020-03-20 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES

Country Status (1)

Country Link
EA (1) EA202192584A1 (en)

Similar Documents

Publication Publication Date Title
MX2021011507A (en) Pharmaceutical compounds for the treatment of complement mediated disorders.
EA201890725A1 (en) PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION
BR112019000692A2 (en) Somatostatin modulators and uses of these
EA202092490A1 (en) METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MX2023002507A (en) Cd73 inhibitors.
MX2017016134A (en) Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease.
NZ757081A (en) Somatostatin modulators and uses thereof
MX2020011234A (en) Nlrp3 modulators.
EA201891399A1 (en) BIPIRAZOLE DERIVATIVES, SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
MX2017009417A (en) Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof.
SA519410320B1 (en) Phenyl-2-Hydroxy-Acetylamino-2-Methyl-Phenyl Compounds
EA201990400A1 (en) COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
MX2020007586A (en) Process of making somatostatin modulators.
BR112021019070A2 (en) tyk2 pseudokinase ligands
NZ761519A (en) Nlrp3 modulators
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
CR20220215A (en) Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
PH12021550872A1 (en) Therapeutic compounds
CR20220216A (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
BR112018003776A2 (en) fused heterocyclic compounds as s1p modulators
BR112022000855A2 (en) nlrp3 modulators
EP3841086A4 (en) Pharmaceutical compounds for the treatment of complement factor d medical disorders
EA202191115A1 (en) NEW PYRIDAZINES
EA201890460A1 (en) COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS